Bank Of America Sees 4Q Beat And Exchange Trends Boost Shares For Towers Watson & Co.

In a report published Wednesday, Bank of America analyst Sara Gubins reiterated a Buy rating and $137.00 price target on

. In the report, Bank of America noted, “We forecast mid-single-digit revenue growth over the medium-term along with 30-40bp of margin expansion per year. Towers Watson is the leader in the Medicare-eligible employer-sponsored private health care exchange market and is seeking to expand into other health care ex changes for active employees. This is an area of significant growth potential, in our view.” Towers Watson & Co. closed on Tuesday at $105.80.